Title: Why are most phospholipidosis inducers also hERG blockers?
Journal: Archives of toxicology 20171201
Title: New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.
Journal: Bioorganic & medicinal chemistry letters 20111101
Title: A novel flow cytometric high throughput assay for a systematic study on molecular mechanisms underlying T cell receptor-mediated integrin activation.
Journal: PloS one 20090101
Title: Stereoselective total synthesis of bioactive styryllactones (+)-goniofufurone, (+)7-epi-goniofufurone, (+)-goniopypyrone, (+)-goniotriol, (+)-altholactone, and (-)-etharvensin.
Journal: The Journal of organic chemistry 20080104
Title: Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, antimalarial, cytotoxic, and anti-HIV agents.
Journal: Bioorganic & medicinal chemistry 20011101
Title: Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
Journal: Biological & pharmaceutical bulletin 20010701
Title: Characterization of TbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from the protozoan parasite Trypanosoma brucei.
Journal: The Journal of biological chemistry 20010413
Title: Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells.
Journal: Biological & pharmaceutical bulletin 20010101
Title: Tumor- and drug-induced cutaneous neuro-phospholipidosis.
Journal: Journal of cutaneous pathology 19750101